Good afternoon, everyone, and thank you for joining us. I'm David Moss, CEO of INmune Bio. Today, we're proud to share pivotal updates regarding our MissionEB Phase III clinical trial and the impact ...
Why the beauty industry is shifting from claims to measurable skin performance What we are seeing is not a rejection of skincare, but a recalibration of expectations. Clients today no longer accept ...
What we are seeing is not a rejection of skincare, but a recalibration of expectations. Clients today no longer accept uncertainty. They expect structure, logic, and predictable results.” — Stefan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results